Corcept Therapeutics
CORT
#2462
Rank
A$10.51 B
Marketcap
A$96.12
Share price
-2.09%
Change (1 day)
-18.54%
Change (1 year)

EPS for Corcept Therapeutics (CORT)

EPS in 2026 (TTM): A$2.17

According to Corcept Therapeutics 's latest financial reports the company's current EPS (TTM) is A$2.27. In 2025 the company made an earnings per share (EPS) of A$1.42 a decrease over its 2024 EPS that were of A$2.04.

EPS history for Corcept Therapeutics from 2017 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$2.1753.01%
2025A$1.42-30.37%
2024A$2.04
2022A$1.44-2.06%
2021A$1.475.43%
2020A$1.3910.84%
2019A$1.2527.69%
2018A$0.98-42.48%
2017A$1.71

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$10.09 345.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$7.93 250.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.07-52.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$46.67 1,959.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$1.50-33.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$6.83 201.33%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
A-$0.20-108.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A-$0.03022-101.33%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A-$0.14-106.00%๐Ÿ‡บ๐Ÿ‡ธ USA